Fundamentals

Why Litigation Funding Works Like Venture Capital, Not a Loan

The first instinct most claimants bring to a funding conversation is a lending frame: what is the rate, when is it due, what happens if I cannot pay. That frame is wrong, and understanding why changes how you should negotiate. In her 2012 William & Mary Law Review article "The Litigation Finance Contract," Maya Steinitz argued that earlier scholarship had reached for the wrong analogy when it compared funding to a contingency fee arrangement. The better comparison, she argued, is venture capital, because both relationships share the same three structural features: extreme uncertainty about the eventual outcome, a severe information gap between the party who knows the underlying facts and the party supplying the money, and high agency costs once capital is committed and incentives can drift apart.

That reframe is not academic decoration. It explains concrete features of a real funding agreement that a lending frame cannot. Funding is non-recourse, like an equity check and unlike a loan, because the funder is buying a contingent stake in an outcome rather than lending against a borrower's general ability to repay. Funders ask for detailed information rights and regular case updates for the same reason a venture investor asks for board reporting, not because they distrust the claimant, but because the information asymmetry that made the deal necessary in the first place does not close on the day the check is signed. And the empirical record backs the analogy: a 2003 study of real venture financings by Steven Kaplan and Per Strömberg of the University of Chicago Booth School of Business found that actual VC contracts separately allocate cash flow rights, board rights, voting rights, and liquidation rights, with roughly 15 percent of financings providing only partial funding at signing, additional capital contingent on the company hitting subsequent milestones. Litigation funders have adapted essentially that same toolkit to claims.

The practical implication for a claimant or a lawyer evaluating a term sheet is to stop asking "what is my interest rate" and start asking the questions a founder asks before taking a term sheet: what does the investor get in exchange for the risk they are absorbing, what happens if I need more capital later on different terms, and what information do I owe them along the way. A funding agreement is a form of equity financing for a lawsuit. Negotiating it like a debt instrument means missing most of what is actually being asked.

← Back to the Research Library